Joanna Wawer

Joanna Wawer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Joanna Wawer has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dyslipidemia Assessed in Pediatric Patients: Validation of LDL-C Assessed by Friedewald Formula, Direct Assessment, and Sampson–NIH Formula

    by Joanna Wawer, Agnieszka Chojęta, Jakub Swadźba, Mariola Janiszewska, Michał Chojęta, Genowefa Anna Wawer, Ewelina Grywalska, Anna Milaniuk

    Background: The epidemic increase in obesity, metabolic syndrome, cardiac disease, or hypertension is associated with lipid deregulation. Studies suggest a strong link between elevated levels of plasma cholesterol and the premature formation of atherosclerotic plaques. Primary prevention of early clinical manifestations of atherosclerosis allows slowing or preventing the development of several health problems later in adult life. Objectives: The purpose of this study was the validation of LDL-C measured by the Friedewald formula, direct method, and Sampson–NIH Formula. The results of the three methods used to assess LDL-C were compared to check whether the three measurements of LDL-C yielded different results. Methods: The study was conducted in a large cohort of in-patients aged 8 months to 18 years. Lipid profile parameters were determined. Indirect methods for dyslipidemia diagnosis were compared against direct LDL measurement. Incorrect and missed diagnoses were analyzed. To measure the central tendency, a statistical analysis of distributions of numerical variables was used. Differences between categorical variables were assessed. The agreement between pairs of competing methods in estimating LDL concentration was assessed via Bland–Altman analysis. Results: In total, 1982 pediatric patients underwent lipid profile assessment. Significant differences in lipid parameters between boys and girls were observed. TG, TC, and HDL levels were higher in boys. LDL-C as measured by the Friedewald formula and direct methods showed significant differences. Comparison of the direct methods with the Sampson–NIH indicated that the Sampson–NIH formula underestimates LDL values. Conclusions: The analysis revealed differences between the methods used to assess dyslipidemia. A systematic underestimation of LDL concentrations determined by the indirect methods was found. Small differences between the Friedewald and Sampson–NIH methods were observed. Although both indirect methods underestimate LDL levels compared to the direct method, the differences between them are small, though still detectable.

  • Open Access

    The Significance of Serum Immunoglobulin Concentrations in Children with Autism Spectrum Disorders: In Search of Potential Blood Biomarkers

    by Joanna Wawer, Agnieszka Chojęta, Genowefa Anna Wawer, Marcin Gładki, Aneta Klotzka, Bartłomiej Kociński, Tomasz Urbanowicz, Janusz Kocki, Ewelina Grywalska

    Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders characterized by a number of dysfunctions in communication, social interactions and repetitive rigid patterns of behavior, interests, and activities. Despite much research, the causes of ASD remain elusive. In addition to genetic and epigenetic etiology, scientists have indicated inflammation, deregulation of cytokines, anti-brain autoantibodies, gut microbiota, and deregulated immunity as mechanisms possibly involved in the development of ASD phenotype. The aim of the study was to analyze the levels of IgA, IgE, and IgM immunoglobulins in the blood serum in patients with ASD to find out whether certain blood parameters are deregulated in that group of patients. The results suggest altered production of the immune cells in ASD patients which may be considered in the assessment of immune functions. Also, PCT% and LYMPH elevated values in patients with ASD might be of clinical relevance, possibly of predictive value for clinical preliminary diagnosis and therapy.